Form 4: Eyenovia CEO Michael Rowe Increases Stake in Company
SEC Form 4
Eyenovia's CEO, Michael Rowe, acquired 27,071 shares of common stock at $0.52 per share on August 28, 2024, increasing his direct holdings.
Summary
- On August 28, 2024, Michael Rowe, the CEO of Eyenovia, Inc., purchased 27,071 shares of the company's common stock.
- The purchase price was $0.52 per share.
- Following the transaction, Rowe directly owns 109,998 shares of Eyenovia.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is generally a good sign, but the document itself is simply a report of the transaction.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued.
Key Dates
| Date | Description |
|---|---|
| 08/28/2024 | Date of transaction: Michael Rowe purchased 27,071 shares of Eyenovia common stock. |
Keywords
Eyenovia, Michael Rowe, insider trading, stock purchase, common stock, EYEN
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.